Indomethacin for injection is indicated to close a hemodynamically patent ductus arteriosus in premature infants, who typically have small blood vessels. The voluntary recall was initiated because some
Following the transaction, which is still subject to approval of Peoples Republic of China’s authorities, GSK will become the sole owner of GSKNB. With this acquisition, GSK intends
The Consent Decree is subject to approval by the US District Court in the Eastern District of Wisconsin. H&P has enlisted an independent expert who will inspect the
Easton will continue to serve as chairman of the board following the appointment of the company’s new CEO. He has spent the past eight years managing research projects
Orexo is planning to start and conclude the next clinical study in healthy volunteers in the fourth quarter of 2011. Orexo president and CEO Anders Lundstrom said OX27
The company’s decision follows two years of expansion and investment in a £15m laboratory in Cardiff. Quotient Bioresearch, a provider of early stage drug development services to pharmaceutical
Suzhou Erye is a subsidiary of NeoStem, which is engaged in the development and manufacturing of cell-based therapies in the US. The combined production lines now certified by
The drug delivery system is a two-compartment, flexible, eco-friendly IV container that stores pre-measured drug and diluent doses. DUPLEX can be stored at room temperature and fits in
The companies can now offer marketing and commercialization rights for Ondansetron ODF in Europe and selected Non-European countries, either through global, regional or local license agreements. Ondansetron ODF
Following the acquisition, inVentiv Health’s clinical segment comprises i3, along with inVentiv’s existing clinical businesses and PharmaNet Development Group. i3 CEO Glenn Bilawsky said for their clients, this
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.